FDA's Budget Flat In House Bill, But Path For 'Cures' Funding Cleared
US agency's budget authority would remain at current level under FY 2018 appropriations bill reported out by a House subcommittee; measure includes language enabling FDA's Oncology Center of Excellence to receive 21st Century Cures funding transferred from National institutes of Health.
You may also be interested in...
Cures 2.0 Would Mandate More FDA Centers of Excellence But Oncology-Style Funding Gaps Could Doom Plan
The two new intercenter institutes, one to focus on a common group of diseases and the other on rare diseases, appear to be unfunded mandates, which could hinder the agency’s ability to get them up and running.
Commissioner Gottlieb says new centers would follow template of Oncology Center of Excellence.
Appropriations bill report includes language stating that it is 'imperative' the agency take all steps necessary to require opioid prescriber training.